0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pregabalin Market Insights, Forecast to 2030
Published Date: September 2024
|
Report Code: QYRE-Auto-21O7531
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Pregabalin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Pregabalin Market Insights, Forecast to 2030

Code: QYRE-Auto-21O7531
Report
September 2024
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pregabalin Market Size

The global Pregabalin market is projected to grow from US$ 1302 million in 2024 to US$ 1764.8 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.

Pregabalin Market

Pregabalin Market

Pregabalin is an anticonvulsant drug used for the treatment of epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its mode of action involves decrease in pain signals sent by the damaged nerves in the body.
Increase in geriatric population suffering from neuropathic diabetes and rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market. 
Report Covers:
This report presents an overview of global market for Pregabalin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pregabalin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pregabalin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pregabalin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pregabalin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pregabalin sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Pregabalin Market Report

Report Metric Details
Report Name Pregabalin Market
Accounted market size in 2024 US$ 1302 million
Forecasted market size in 2030 US$ 1764.8 million
CAGR 5.2
Base Year 2024
Forecasted years 2024 - 2030
Segment by Type
  • Tablet
  • Capsule
  • Oral Solution
Segment by Application
  • Hospitals
  • Clinics
  • Others
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AASraw Biochemical Technology, Changzhou Pharmaceutical Factory (CPF), Almelo Pvt. Ltd., Divi’s Laboratories, Angels Pharma, ARITE Pharmaceutical, BAL Pharma, Bazayan, Aurobindo Pharma, Hikal, Glenmark Life Sciences, Dongbang FTL, Teva Pharmaceutical Industries, Chemo Iberica, Maps Laboratories, Laurus Labs, Zhejiang Huahai Pharmaceutical, Vasudha Pharma Chem, Sun Pharmaceutical Industries, CTX Life Sciences, Srini Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Pregabalin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Pregabalin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pregabalin sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Pregabalin Market growing?

Ans: The Pregabalin Market witnessing a CAGR of 5.2 during the forecast period 2024-2030.

What is the Pregabalin Market size in 2030?

Ans: The Pregabalin Market size in 2030 will be US$ 1764.8 million.

Who are the main players in the Pregabalin Market report?

Ans: The main players in the Pregabalin Market are AASraw Biochemical Technology, Changzhou Pharmaceutical Factory (CPF), Almelo Pvt. Ltd., Divi’s Laboratories, Angels Pharma, ARITE Pharmaceutical, BAL Pharma, Bazayan, Aurobindo Pharma, Hikal, Glenmark Life Sciences, Dongbang FTL, Teva Pharmaceutical Industries, Chemo Iberica, Maps Laboratories, Laurus Labs, Zhejiang Huahai Pharmaceutical, Vasudha Pharma Chem, Sun Pharmaceutical Industries, CTX Life Sciences, Srini Pharmaceuticals

What are the Application segmentation covered in the Pregabalin Market report?

Ans: The Applications covered in the Pregabalin Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Pregabalin Market report?

Ans: The Types covered in the Pregabalin Market report are Tablet, Capsule, Oral Solution

1 Study Coverage
1.1 Pregabalin Product Introduction
1.2 Market by Type
1.2.1 Global Pregabalin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Oral Solution
1.3 Market by Application
1.3.1 Global Pregabalin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pregabalin Sales Estimates and Forecasts 2019-2030
2.2 Global Pregabalin Revenue by Region
2.2.1 Global Pregabalin Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Pregabalin Revenue by Region (2019-2024)
2.2.3 Global Pregabalin Revenue by Region (2025-2030)
2.2.4 Global Pregabalin Revenue Market Share by Region (2019-2030)
2.3 Global Pregabalin Sales Estimates and Forecasts 2019-2030
2.4 Global Pregabalin Sales by Region
2.4.1 Global Pregabalin Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Pregabalin Sales by Region (2019-2024)
2.4.3 Global Pregabalin Sales by Region (2025-2030)
2.4.4 Global Pregabalin Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Pregabalin Sales by Manufacturers
3.1.1 Global Pregabalin Sales by Manufacturers (2019-2024)
3.1.2 Global Pregabalin Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pregabalin in 2023
3.2 Global Pregabalin Revenue by Manufacturers
3.2.1 Global Pregabalin Revenue by Manufacturers (2019-2024)
3.2.2 Global Pregabalin Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Pregabalin Revenue in 2023
3.3 Global Key Players of Pregabalin, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Pregabalin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pregabalin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pregabalin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pregabalin, Product Offered and Application
3.8 Global Key Manufacturers of Pregabalin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pregabalin Sales by Type
4.1.1 Global Pregabalin Historical Sales by Type (2019-2024)
4.1.2 Global Pregabalin Forecasted Sales by Type (2025-2030)
4.1.3 Global Pregabalin Sales Market Share by Type (2019-2030)
4.2 Global Pregabalin Revenue by Type
4.2.1 Global Pregabalin Historical Revenue by Type (2019-2024)
4.2.2 Global Pregabalin Forecasted Revenue by Type (2025-2030)
4.2.3 Global Pregabalin Revenue Market Share by Type (2019-2030)
4.3 Global Pregabalin Price by Type
4.3.1 Global Pregabalin Price by Type (2019-2024)
4.3.2 Global Pregabalin Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Pregabalin Sales by Application
5.1.1 Global Pregabalin Historical Sales by Application (2019-2024)
5.1.2 Global Pregabalin Forecasted Sales by Application (2025-2030)
5.1.3 Global Pregabalin Sales Market Share by Application (2019-2030)
5.2 Global Pregabalin Revenue by Application
5.2.1 Global Pregabalin Historical Revenue by Application (2019-2024)
5.2.2 Global Pregabalin Forecasted Revenue by Application (2025-2030)
5.2.3 Global Pregabalin Revenue Market Share by Application (2019-2030)
5.3 Global Pregabalin Price by Application
5.3.1 Global Pregabalin Price by Application (2019-2024)
5.3.2 Global Pregabalin Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Pregabalin Market Size by Type
6.1.1 US & Canada Pregabalin Sales by Type (2019-2030)
6.1.2 US & Canada Pregabalin Revenue by Type (2019-2030)
6.2 US & Canada Pregabalin Market Size by Application
6.2.1 US & Canada Pregabalin Sales by Application (2019-2030)
6.2.2 US & Canada Pregabalin Revenue by Application (2019-2030)
6.3 US & Canada Pregabalin Market Size by Country
6.3.1 US & Canada Pregabalin Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Pregabalin Sales by Country (2019-2030)
6.3.3 US & Canada Pregabalin Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Pregabalin Market Size by Type
7.1.1 Europe Pregabalin Sales by Type (2019-2030)
7.1.2 Europe Pregabalin Revenue by Type (2019-2030)
7.2 Europe Pregabalin Market Size by Application
7.2.1 Europe Pregabalin Sales by Application (2019-2030)
7.2.2 Europe Pregabalin Revenue by Application (2019-2030)
7.3 Europe Pregabalin Market Size by Country
7.3.1 Europe Pregabalin Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Pregabalin Sales by Country (2019-2030)
7.3.3 Europe Pregabalin Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Pregabalin Market Size
8.1.1 China Pregabalin Sales (2019-2030)
8.1.2 China Pregabalin Revenue (2019-2030)
8.2 China Pregabalin Market Size by Application
8.2.1 China Pregabalin Sales by Application (2019-2030)
8.2.2 China Pregabalin Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Pregabalin Market Size by Type
9.1.1 Asia Pregabalin Sales by Type (2019-2030)
9.1.2 Asia Pregabalin Revenue by Type (2019-2030)
9.2 Asia Pregabalin Market Size by Application
9.2.1 Asia Pregabalin Sales by Application (2019-2030)
9.2.2 Asia Pregabalin Revenue by Application (2019-2030)
9.3 Asia Pregabalin Sales by Region
9.3.1 Asia Pregabalin Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Pregabalin Revenue by Region (2019-2030)
9.3.3 Asia Pregabalin Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pregabalin Market Size by Type
10.1.1 Middle East, Africa and Latin America Pregabalin Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Pregabalin Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Pregabalin Market Size by Application
10.2.1 Middle East, Africa and Latin America Pregabalin Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Pregabalin Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Pregabalin Sales by Country
10.3.1 Middle East, Africa and Latin America Pregabalin Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Pregabalin Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Pregabalin Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 ZCL Chemicals
11.1.1 ZCL Chemicals Company Information
11.1.2 ZCL Chemicals Overview
11.1.3 ZCL Chemicals Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 ZCL Chemicals Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ZCL Chemicals Recent Developments
11.2 Olon S.p.A.
11.2.1 Olon S.p.A. Company Information
11.2.2 Olon S.p.A. Overview
11.2.3 Olon S.p.A. Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Olon S.p.A. Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Olon S.p.A. Recent Developments
11.3 AASraw Biochemical Technology
11.3.1 AASraw Biochemical Technology Company Information
11.3.2 AASraw Biochemical Technology Overview
11.3.3 AASraw Biochemical Technology Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 AASraw Biochemical Technology Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AASraw Biochemical Technology Recent Developments
11.4 Changzhou Pharmaceutical Factory (CPF)
11.4.1 Changzhou Pharmaceutical Factory (CPF) Company Information
11.4.2 Changzhou Pharmaceutical Factory (CPF) Overview
11.4.3 Changzhou Pharmaceutical Factory (CPF) Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Changzhou Pharmaceutical Factory (CPF) Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Changzhou Pharmaceutical Factory (CPF) Recent Developments
11.5 Almelo Pvt. Ltd.
11.5.1 Almelo Pvt. Ltd. Company Information
11.5.2 Almelo Pvt. Ltd. Overview
11.5.3 Almelo Pvt. Ltd. Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Almelo Pvt. Ltd. Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Almelo Pvt. Ltd. Recent Developments
11.6 Divi’s Laboratories
11.6.1 Divi’s Laboratories Company Information
11.6.2 Divi’s Laboratories Overview
11.6.3 Divi’s Laboratories Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Divi’s Laboratories Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Divi’s Laboratories Recent Developments
11.7 Angels Pharma
11.7.1 Angels Pharma Company Information
11.7.2 Angels Pharma Overview
11.7.3 Angels Pharma Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Angels Pharma Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Angels Pharma Recent Developments
11.8 ARITE Pharmaceutical
11.8.1 ARITE Pharmaceutical Company Information
11.8.2 ARITE Pharmaceutical Overview
11.8.3 ARITE Pharmaceutical Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 ARITE Pharmaceutical Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 ARITE Pharmaceutical Recent Developments
11.9 BAL Pharma
11.9.1 BAL Pharma Company Information
11.9.2 BAL Pharma Overview
11.9.3 BAL Pharma Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 BAL Pharma Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 BAL Pharma Recent Developments
11.10 Bazayan
11.10.1 Bazayan Company Information
11.10.2 Bazayan Overview
11.10.3 Bazayan Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Bazayan Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bazayan Recent Developments
11.11 Aurobindo Pharma
11.11.1 Aurobindo Pharma Company Information
11.11.2 Aurobindo Pharma Overview
11.11.3 Aurobindo Pharma Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Aurobindo Pharma Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Aurobindo Pharma Recent Developments
11.12 Hikal
11.12.1 Hikal Company Information
11.12.2 Hikal Overview
11.12.3 Hikal Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Hikal Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Hikal Recent Developments
11.13 Glenmark Life Sciences
11.13.1 Glenmark Life Sciences Company Information
11.13.2 Glenmark Life Sciences Overview
11.13.3 Glenmark Life Sciences Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Glenmark Life Sciences Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Glenmark Life Sciences Recent Developments
11.14 Dongbang FTL
11.14.1 Dongbang FTL Company Information
11.14.2 Dongbang FTL Overview
11.14.3 Dongbang FTL Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Dongbang FTL Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Dongbang FTL Recent Developments
11.15 Teva Pharmaceutical Industries
11.15.1 Teva Pharmaceutical Industries Company Information
11.15.2 Teva Pharmaceutical Industries Overview
11.15.3 Teva Pharmaceutical Industries Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Teva Pharmaceutical Industries Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Teva Pharmaceutical Industries Recent Developments
11.16 Divi’s Laboratories
11.16.1 Divi’s Laboratories Company Information
11.16.2 Divi’s Laboratories Overview
11.16.3 Divi’s Laboratories Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.16.4 Divi’s Laboratories Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Divi’s Laboratories Recent Developments
11.17 Chemo Iberica
11.17.1 Chemo Iberica Company Information
11.17.2 Chemo Iberica Overview
11.17.3 Chemo Iberica Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.17.4 Chemo Iberica Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Chemo Iberica Recent Developments
11.18 Maps Laboratories
11.18.1 Maps Laboratories Company Information
11.18.2 Maps Laboratories Overview
11.18.3 Maps Laboratories Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.18.4 Maps Laboratories Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Maps Laboratories Recent Developments
11.19 Laurus Labs
11.19.1 Laurus Labs Company Information
11.19.2 Laurus Labs Overview
11.19.3 Laurus Labs Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.19.4 Laurus Labs Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Laurus Labs Recent Developments
11.20 Zhejiang Huahai Pharmaceutical
11.20.1 Zhejiang Huahai Pharmaceutical Company Information
11.20.2 Zhejiang Huahai Pharmaceutical Overview
11.20.3 Zhejiang Huahai Pharmaceutical Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.20.4 Zhejiang Huahai Pharmaceutical Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Zhejiang Huahai Pharmaceutical Recent Developments
11.21 Vasudha Pharma Chem
11.21.1 Vasudha Pharma Chem Company Information
11.21.2 Vasudha Pharma Chem Overview
11.21.3 Vasudha Pharma Chem Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.21.4 Vasudha Pharma Chem Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Vasudha Pharma Chem Recent Developments
11.22 Sun Pharmaceutical Industries
11.22.1 Sun Pharmaceutical Industries Company Information
11.22.2 Sun Pharmaceutical Industries Overview
11.22.3 Sun Pharmaceutical Industries Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.22.4 Sun Pharmaceutical Industries Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Sun Pharmaceutical Industries Recent Developments
11.23 CTX Life Sciences
11.23.1 CTX Life Sciences Company Information
11.23.2 CTX Life Sciences Overview
11.23.3 CTX Life Sciences Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.23.4 CTX Life Sciences Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 CTX Life Sciences Recent Developments
11.24 Srini Pharmaceuticals
11.24.1 Srini Pharmaceuticals Company Information
11.24.2 Srini Pharmaceuticals Overview
11.24.3 Srini Pharmaceuticals Pregabalin Sales, Price, Revenue and Gross Margin (2019-2024)
11.24.4 Srini Pharmaceuticals Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Srini Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pregabalin Industry Chain Analysis
12.2 Pregabalin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pregabalin Production Mode & Process
12.4 Pregabalin Sales and Marketing
12.4.1 Pregabalin Sales Channels
12.4.2 Pregabalin Distributors
12.5 Pregabalin Customers
13 Market Dynamics
13.1 Pregabalin Industry Trends
13.2 Pregabalin Market Drivers
13.3 Pregabalin Market Challenges
13.4 Pregabalin Market Restraints
14 Key Findings in The Global Pregabalin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Pregabalin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Tablet
    Table 3. Major Manufacturers of Capsule
    Table 4. Major Manufacturers of Oral Solution
    Table 5. Global Pregabalin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Pregabalin Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Pregabalin Revenue by Region (2019-2024) & (US$ Million)
    Table 8. Global Pregabalin Revenue by Region (2025-2030) & (US$ Million)
    Table 9. Global Pregabalin Revenue Market Share by Region (2019-2024)
    Table 10. Global Pregabalin Revenue Market Share by Region (2025-2030)
    Table 11. Global Pregabalin Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 12. Global Pregabalin Sales by Region (2019-2024) & (K MT)
    Table 13. Global Pregabalin Sales by Region (2025-2030) & (K MT)
    Table 14. Global Pregabalin Sales Market Share by Region (2019-2024)
    Table 15. Global Pregabalin Sales Market Share by Region (2025-2030)
    Table 16. Global Pregabalin Sales by Manufacturers (2019-2024) & (K MT)
    Table 17. Global Pregabalin Sales Share by Manufacturers (2019-2024)
    Table 18. Global Pregabalin Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 19. Global Pregabalin Revenue Share by Manufacturers (2019-2024)
    Table 20. Global Key Players of Pregabalin, Industry Ranking, 2022 VS 2023 VS 2024
    Table 21. Pregabalin Price by Manufacturers 2019-2024 (USD/MT)
    Table 22. Global Pregabalin Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Pregabalin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pregabalin as of 2023)
    Table 24. Global Key Manufacturers of Pregabalin, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Pregabalin, Product Offered and Application
    Table 26. Global Key Manufacturers of Pregabalin, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Pregabalin Sales by Type (2019-2024) & (K MT)
    Table 29. Global Pregabalin Sales by Type (2025-2030) & (K MT)
    Table 30. Global Pregabalin Sales Share by Type (2019-2024)
    Table 31. Global Pregabalin Sales Share by Type (2025-2030)
    Table 32. Global Pregabalin Revenue by Type (2019-2024) & (US$ Million)
    Table 33. Global Pregabalin Revenue by Type (2025-2030) & (US$ Million)
    Table 34. Global Pregabalin Revenue Share by Type (2019-2024)
    Table 35. Global Pregabalin Revenue Share by Type (2025-2030)
    Table 36. Pregabalin Price by Type (2019-2024) & (USD/MT)
    Table 37. Global Pregabalin Price Forecast by Type (2025-2030) & (USD/MT)
    Table 38. Global Pregabalin Sales by Application (2019-2024) & (K MT)
    Table 39. Global Pregabalin Sales by Application (2025-2030) & (K MT)
    Table 40. Global Pregabalin Sales Share by Application (2019-2024)
    Table 41. Global Pregabalin Sales Share by Application (2025-2030)
    Table 42. Global Pregabalin Revenue by Application (2019-2024) & (US$ Million)
    Table 43. Global Pregabalin Revenue by Application (2025-2030) & (US$ Million)
    Table 44. Global Pregabalin Revenue Share by Application (2019-2024)
    Table 45. Global Pregabalin Revenue Share by Application (2025-2030)
    Table 46. Pregabalin Price by Application (2019-2024) & (USD/MT)
    Table 47. Global Pregabalin Price Forecast by Application (2025-2030) & (USD/MT)
    Table 48. US & Canada Pregabalin Sales by Type (2019-2024) & (K MT)
    Table 49. US & Canada Pregabalin Sales by Type (2025-2030) & (K MT)
    Table 50. US & Canada Pregabalin Revenue by Type (2019-2024) & (US$ Million)
    Table 51. US & Canada Pregabalin Revenue by Type (2025-2030) & (US$ Million)
    Table 52. US & Canada Pregabalin Sales by Application (2019-2024) & (K MT)
    Table 53. US & Canada Pregabalin Sales by Application (2025-2030) & (K MT)
    Table 54. US & Canada Pregabalin Revenue by Application (2019-2024) & (US$ Million)
    Table 55. US & Canada Pregabalin Revenue by Application (2025-2030) & (US$ Million)
    Table 56. US & Canada Pregabalin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 57. US & Canada Pregabalin Revenue by Country (2019-2024) & (US$ Million)
    Table 58. US & Canada Pregabalin Revenue by Country (2025-2030) & (US$ Million)
    Table 59. US & Canada Pregabalin Sales by Country (2019-2024) & (K MT)
    Table 60. US & Canada Pregabalin Sales by Country (2025-2030) & (K MT)
    Table 61. Europe Pregabalin Sales by Type (2019-2024) & (K MT)
    Table 62. Europe Pregabalin Sales by Type (2025-2030) & (K MT)
    Table 63. Europe Pregabalin Revenue by Type (2019-2024) & (US$ Million)
    Table 64. Europe Pregabalin Revenue by Type (2025-2030) & (US$ Million)
    Table 65. Europe Pregabalin Sales by Application (2019-2024) & (K MT)
    Table 66. Europe Pregabalin Sales by Application (2025-2030) & (K MT)
    Table 67. Europe Pregabalin Revenue by Application (2019-2024) & (US$ Million)
    Table 68. Europe Pregabalin Revenue by Application (2025-2030) & (US$ Million)
    Table 69. Europe Pregabalin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 70. Europe Pregabalin Revenue by Country (2019-2024) & (US$ Million)
    Table 71. Europe Pregabalin Revenue by Country (2025-2030) & (US$ Million)
    Table 72. Europe Pregabalin Sales by Country (2019-2024) & (K MT)
    Table 73. Europe Pregabalin Sales by Country (2025-2030) & (K MT)
    Table 74. China Pregabalin Sales by Type (2019-2024) & (K MT)
    Table 75. China Pregabalin Sales by Type (2025-2030) & (K MT)
    Table 76. China Pregabalin Revenue by Type (2019-2024) & (US$ Million)
    Table 77. China Pregabalin Revenue by Type (2025-2030) & (US$ Million)
    Table 78. China Pregabalin Sales by Application (2019-2024) & (K MT)
    Table 79. China Pregabalin Sales by Application (2025-2030) & (K MT)
    Table 80. China Pregabalin Revenue by Application (2019-2024) & (US$ Million)
    Table 81. China Pregabalin Revenue by Application (2025-2030) & (US$ Million)
    Table 82. Asia Pregabalin Sales by Type (2019-2024) & (K MT)
    Table 83. Asia Pregabalin Sales by Type (2025-2030) & (K MT)
    Table 84. Asia Pregabalin Revenue by Type (2019-2024) & (US$ Million)
    Table 85. Asia Pregabalin Revenue by Type (2025-2030) & (US$ Million)
    Table 86. Asia Pregabalin Sales by Application (2019-2024) & (K MT)
    Table 87. Asia Pregabalin Sales by Application (2025-2030) & (K MT)
    Table 88. Asia Pregabalin Revenue by Application (2019-2024) & (US$ Million)
    Table 89. Asia Pregabalin Revenue by Application (2025-2030) & (US$ Million)
    Table 90. Asia Pregabalin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 91. Asia Pregabalin Revenue by Region (2019-2024) & (US$ Million)
    Table 92. Asia Pregabalin Revenue by Region (2025-2030) & (US$ Million)
    Table 93. Asia Pregabalin Sales by Region (2019-2024) & (K MT)
    Table 94. Asia Pregabalin Sales by Region (2025-2030) & (K MT)
    Table 95. Middle East, Africa and Latin America Pregabalin Sales by Type (2019-2024) & (K MT)
    Table 96. Middle East, Africa and Latin America Pregabalin Sales by Type (2025-2030) & (K MT)
    Table 97. Middle East, Africa and Latin America Pregabalin Revenue by Type (2019-2024) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Pregabalin Revenue by Type (2025-2030) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Pregabalin Sales by Application (2019-2024) & (K MT)
    Table 100. Middle East, Africa and Latin America Pregabalin Sales by Application (2025-2030) & (K MT)
    Table 101. Middle East, Africa and Latin America Pregabalin Revenue by Application (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Pregabalin Revenue by Application (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Pregabalin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 104. Middle East, Africa and Latin America Pregabalin Revenue by Country (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Pregabalin Revenue by Country (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Pregabalin Sales by Country (2019-2024) & (K MT)
    Table 107. Middle East, Africa and Latin America Pregabalin Sales by Country (2025-2030) & (K MT)
    Table 108. ZCL Chemicals Company Information
    Table 109. ZCL Chemicals Description and Major Businesses
    Table 110. ZCL Chemicals Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 111. ZCL Chemicals Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. ZCL Chemicals Recent Developments
    Table 113. Olon S.p.A. Company Information
    Table 114. Olon S.p.A. Description and Major Businesses
    Table 115. Olon S.p.A. Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 116. Olon S.p.A. Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Olon S.p.A. Recent Developments
    Table 118. AASraw Biochemical Technology Company Information
    Table 119. AASraw Biochemical Technology Description and Major Businesses
    Table 120. AASraw Biochemical Technology Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 121. AASraw Biochemical Technology Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. AASraw Biochemical Technology Recent Developments
    Table 123. Changzhou Pharmaceutical Factory (CPF) Company Information
    Table 124. Changzhou Pharmaceutical Factory (CPF) Description and Major Businesses
    Table 125. Changzhou Pharmaceutical Factory (CPF) Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 126. Changzhou Pharmaceutical Factory (CPF) Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Changzhou Pharmaceutical Factory (CPF) Recent Developments
    Table 128. Almelo Pvt. Ltd. Company Information
    Table 129. Almelo Pvt. Ltd. Description and Major Businesses
    Table 130. Almelo Pvt. Ltd. Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 131. Almelo Pvt. Ltd. Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Almelo Pvt. Ltd. Recent Developments
    Table 133. Divi’s Laboratories Company Information
    Table 134. Divi’s Laboratories Description and Major Businesses
    Table 135. Divi’s Laboratories Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 136. Divi’s Laboratories Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Divi’s Laboratories Recent Developments
    Table 138. Angels Pharma Company Information
    Table 139. Angels Pharma Description and Major Businesses
    Table 140. Angels Pharma Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 141. Angels Pharma Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Angels Pharma Recent Developments
    Table 143. ARITE Pharmaceutical Company Information
    Table 144. ARITE Pharmaceutical Description and Major Businesses
    Table 145. ARITE Pharmaceutical Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 146. ARITE Pharmaceutical Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. ARITE Pharmaceutical Recent Developments
    Table 148. BAL Pharma Company Information
    Table 149. BAL Pharma Description and Major Businesses
    Table 150. BAL Pharma Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 151. BAL Pharma Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. BAL Pharma Recent Developments
    Table 153. Bazayan Company Information
    Table 154. Bazayan Description and Major Businesses
    Table 155. Bazayan Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 156. Bazayan Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Bazayan Recent Developments
    Table 158. Aurobindo Pharma Company Information
    Table 159. Aurobindo Pharma Description and Major Businesses
    Table 160. Aurobindo Pharma Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 161. Aurobindo Pharma Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. Aurobindo Pharma Recent Developments
    Table 163. Hikal Company Information
    Table 164. Hikal Description and Major Businesses
    Table 165. Hikal Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 166. Hikal Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. Hikal Recent Developments
    Table 168. Glenmark Life Sciences Company Information
    Table 169. Glenmark Life Sciences Description and Major Businesses
    Table 170. Glenmark Life Sciences Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 171. Glenmark Life Sciences Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. Glenmark Life Sciences Recent Developments
    Table 173. Dongbang FTL Company Information
    Table 174. Dongbang FTL Description and Major Businesses
    Table 175. Dongbang FTL Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 176. Dongbang FTL Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 177. Dongbang FTL Recent Developments
    Table 178. Teva Pharmaceutical Industries Company Information
    Table 179. Teva Pharmaceutical Industries Description and Major Businesses
    Table 180. Teva Pharmaceutical Industries Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 181. Teva Pharmaceutical Industries Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 182. Teva Pharmaceutical Industries Recent Developments
    Table 183. Divi’s Laboratories Company Information
    Table 184. Divi’s Laboratories Description and Major Businesses
    Table 185. Divi’s Laboratories Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 186. Divi’s Laboratories Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 187. Divi’s Laboratories Recent Developments
    Table 188. Chemo Iberica Company Information
    Table 189. Chemo Iberica Description and Major Businesses
    Table 190. Chemo Iberica Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 191. Chemo Iberica Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 192. Chemo Iberica Recent Developments
    Table 193. Maps Laboratories Company Information
    Table 194. Maps Laboratories Description and Major Businesses
    Table 195. Maps Laboratories Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 196. Maps Laboratories Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 197. Maps Laboratories Recent Developments
    Table 198. Laurus Labs Company Information
    Table 199. Laurus Labs Description and Major Businesses
    Table 200. Laurus Labs Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 201. Laurus Labs Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 202. Laurus Labs Recent Developments
    Table 203. Zhejiang Huahai Pharmaceutical Company Information
    Table 204. Zhejiang Huahai Pharmaceutical Description and Major Businesses
    Table 205. Zhejiang Huahai Pharmaceutical Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 206. Zhejiang Huahai Pharmaceutical Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 207. Zhejiang Huahai Pharmaceutical Recent Developments
    Table 208. Vasudha Pharma Chem Company Information
    Table 209. Vasudha Pharma Chem Description and Major Businesses
    Table 210. Vasudha Pharma Chem Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 211. Vasudha Pharma Chem Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 212. Vasudha Pharma Chem Recent Developments
    Table 213. Sun Pharmaceutical Industries Company Information
    Table 214. Sun Pharmaceutical Industries Description and Major Businesses
    Table 215. Sun Pharmaceutical Industries Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 216. Sun Pharmaceutical Industries Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 217. Sun Pharmaceutical Industries Recent Developments
    Table 218. CTX Life Sciences Company Information
    Table 219. CTX Life Sciences Description and Major Businesses
    Table 220. CTX Life Sciences Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 221. CTX Life Sciences Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 222. CTX Life Sciences Recent Developments
    Table 223. Srini Pharmaceuticals Company Information
    Table 224. Srini Pharmaceuticals Description and Major Businesses
    Table 225. Srini Pharmaceuticals Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 226. Srini Pharmaceuticals Pregabalin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 227. Srini Pharmaceuticals Recent Developments
    Table 228. Key Raw Materials Lists
    Table 229. Raw Materials Key Suppliers Lists
    Table 230. Pregabalin Distributors List
    Table 231. Pregabalin Customers List
    Table 232. Pregabalin Market Trends
    Table 233. Pregabalin Market Drivers
    Table 234. Pregabalin Market Challenges
    Table 235. Pregabalin Market Restraints
    Table 236. Research Programs/Design for This Report
    Table 237. Key Data Information from Secondary Sources
    Table 238. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pregabalin Product Picture
    Figure 2. Global Pregabalin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Pregabalin Market Share by Type in 2023 & 2030
    Figure 4. Tablet Product Picture
    Figure 5. Capsule Product Picture
    Figure 6. Oral Solution Product Picture
    Figure 7. Global Pregabalin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Pregabalin Market Share by Application in 2023 & 2030
    Figure 9. Hospitals
    Figure 10. Clinics
    Figure 11. Others
    Figure 12. Pregabalin Report Years Considered
    Figure 13. Global Pregabalin Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Pregabalin Revenue 2019-2030 (US$ Million)
    Figure 15. Global Pregabalin Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 16. Global Pregabalin Revenue Market Share by Region (2019-2030)
    Figure 17. Global Pregabalin Sales 2019-2030 ((K MT)
    Figure 18. Global Pregabalin Sales Market Share by Region (2019-2030)
    Figure 19. US & Canada Pregabalin Sales YoY (2019-2030) & (K MT)
    Figure 20. US & Canada Pregabalin Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. Europe Pregabalin Sales YoY (2019-2030) & (K MT)
    Figure 22. Europe Pregabalin Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. China Pregabalin Sales YoY (2019-2030) & (K MT)
    Figure 24. China Pregabalin Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Asia (excluding China) Pregabalin Sales YoY (2019-2030) & (K MT)
    Figure 26. Asia (excluding China) Pregabalin Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America Pregabalin Sales YoY (2019-2030) & (K MT)
    Figure 28. Middle East, Africa and Latin America Pregabalin Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. The Pregabalin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 30. The Top 5 and 10 Largest Manufacturers of Pregabalin in the World: Market Share by Pregabalin Revenue in 2023
    Figure 31. Global Pregabalin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 32. Global Pregabalin Sales Market Share by Type (2019-2030)
    Figure 33. Global Pregabalin Revenue Market Share by Type (2019-2030)
    Figure 34. Global Pregabalin Sales Market Share by Application (2019-2030)
    Figure 35. Global Pregabalin Revenue Market Share by Application (2019-2030)
    Figure 36. US & Canada Pregabalin Sales Market Share by Type (2019-2030)
    Figure 37. US & Canada Pregabalin Revenue Market Share by Type (2019-2030)
    Figure 38. US & Canada Pregabalin Sales Market Share by Application (2019-2030)
    Figure 39. US & Canada Pregabalin Revenue Market Share by Application (2019-2030)
    Figure 40. US & Canada Pregabalin Revenue Share by Country (2019-2030)
    Figure 41. US & Canada Pregabalin Sales Share by Country (2019-2030)
    Figure 42. U.S. Pregabalin Revenue (2019-2030) & (US$ Million)
    Figure 43. Canada Pregabalin Revenue (2019-2030) & (US$ Million)
    Figure 44. Europe Pregabalin Sales Market Share by Type (2019-2030)
    Figure 45. Europe Pregabalin Revenue Market Share by Type (2019-2030)
    Figure 46. Europe Pregabalin Sales Market Share by Application (2019-2030)
    Figure 47. Europe Pregabalin Revenue Market Share by Application (2019-2030)
    Figure 48. Europe Pregabalin Revenue Share by Country (2019-2030)
    Figure 49. Europe Pregabalin Sales Share by Country (2019-2030)
    Figure 50. Germany Pregabalin Revenue (2019-2030) & (US$ Million)
    Figure 51. France Pregabalin Revenue (2019-2030) & (US$ Million)
    Figure 52. U.K. Pregabalin Revenue (2019-2030) & (US$ Million)
    Figure 53. Italy Pregabalin Revenue (2019-2030) & (US$ Million)
    Figure 54. Russia Pregabalin Revenue (2019-2030) & (US$ Million)
    Figure 55. China Pregabalin Sales Market Share by Type (2019-2030)
    Figure 56. China Pregabalin Revenue Market Share by Type (2019-2030)
    Figure 57. China Pregabalin Sales Market Share by Application (2019-2030)
    Figure 58. China Pregabalin Revenue Market Share by Application (2019-2030)
    Figure 59. Asia Pregabalin Sales Market Share by Type (2019-2030)
    Figure 60. Asia Pregabalin Revenue Market Share by Type (2019-2030)
    Figure 61. Asia Pregabalin Sales Market Share by Application (2019-2030)
    Figure 62. Asia Pregabalin Revenue Market Share by Application (2019-2030)
    Figure 63. Asia Pregabalin Revenue Share by Region (2019-2030)
    Figure 64. Asia Pregabalin Sales Share by Region (2019-2030)
    Figure 65. Japan Pregabalin Revenue (2019-2030) & (US$ Million)
    Figure 66. South Korea Pregabalin Revenue (2019-2030) & (US$ Million)
    Figure 67. China Taiwan Pregabalin Revenue (2019-2030) & (US$ Million)
    Figure 68. Southeast Asia Pregabalin Revenue (2019-2030) & (US$ Million)
    Figure 69. India Pregabalin Revenue (2019-2030) & (US$ Million)
    Figure 70. Middle East, Africa and Latin America Pregabalin Sales Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Pregabalin Revenue Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Pregabalin Sales Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Pregabalin Revenue Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Pregabalin Revenue Share by Country (2019-2030)
    Figure 75. Middle East, Africa and Latin America Pregabalin Sales Share by Country (2019-2030)
    Figure 76. Brazil Pregabalin Revenue (2019-2030) & (US$ Million)
    Figure 77. Mexico Pregabalin Revenue (2019-2030) & (US$ Million)
    Figure 78. Turkey Pregabalin Revenue (2019-2030) & (US$ Million)
    Figure 79. Israel Pregabalin Revenue (2019-2030) & (US$ Million)
    Figure 80. GCC Countries Pregabalin Revenue (2019-2030) & (US$ Million)
    Figure 81. Pregabalin Value Chain
    Figure 82. Pregabalin Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS